GlassScriptPhysician profile
James M Dorchak
NPI 1609972868
$32,792.55
in general payments reported to CMS, 2019-2025
30 companies · $91.90 in 2025
The $91.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $4,314 · 2021: $541 · 2022: $389 · 2023: $487 · 2024: $29.26 · 2025: $91.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,681.95 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Duchesnay USA Incorporated | $15,074.60 | 2019 | |
| Medtronic, INC. | $453.09 | 2021-2025 | Interstim |
| Radius Health, INC. | $279.84 | 2019-2020 | |
| Pfizer INC. | $192.57 | 2019-2022 | |
| Caldera Medical, INC | $141.60 | 2022-2023 | Desara |
| Astellas Pharma US INC | $84.10 | 2019-2023 | Veozah |
| Hologic Sales and Service, LLC | $80.34 | 2019-2023 | Aptima |
| Exeltis, USA INC. | $76.22 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $75.56 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.38 | 2019-2021 | |
| Nuvasive, INC. | $66.74 | 2021 | |
| Zyla Life Sciences, INC. | $52.68 | 2019 | |
| Medtronic USA, INC. | $52.41 | 2019-2020 | |
| Baxter Healthcare | $39.01 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $38.72 | 2020-2022 | |
| Therapeuticsmd, INC. | $38.55 | 2019-2021 | |
| Boston Scientific Corporation | $37.89 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Roche Diagnostics Corporation | $37.82 | 2019 | |
| Ethicon US, LLC | $35.00 | 2020 | |
| Mylan Pharmaceuticals INC. | $30.78 | 2021 | |
| Lupin INC. | $26.12 | 2019-2020 | |
| Avion Pharmaceuticals | $25.64 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.72 | 2022 | |
| Sumitomo Pharma America, INC. | $15.42 | 2023 | Myfembree |
| Coloplast Corp | $15.19 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.77 | 2021 | |
| Conmed Corporation | $14.08 | 2020 | |
| Myovant Sciences INC. | $12.45 | 2022 | |
| Allergan, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dorchak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.